Fibroblast growth factor 9 (FGF9) inhibits myogenic differentiation of C2C12 and human muscle cells

Osteoporosis and sarcopenia (osteosarcopenia (OS)) are twin-aging diseases. The biochemical crosstalk between muscle and bone seems to play a role in OS. We have previously shown that osteocytes produce soluble factors with beneficial effects on muscle and vice versa. Recently, enhanced FGF9 product...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jian, Wang, Kun, Shiflett, Lora A., Brotto, Leticia, Bonewald, Lynda F., Wacker, Michael J., Dallas, Sarah L., Brotto, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927711/
https://www.ncbi.nlm.nih.gov/pubmed/31735119
http://dx.doi.org/10.1080/15384101.2019.1691796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927711/
https://www.ncbi.nlm.nih.gov/pubmed/31735119
http://dx.doi.org/10.1080/15384101.2019.1691796

Ejemplares similares